Keefe Bruyette lifts CME Group Inc. [CME] price estimate. Who else is bullish?



CME Group Inc. [NASDAQ: CME] loss -0.04% or -0.07 points to close at $174.65 with a heavy trading volume of 1967094 shares. It opened the trading session at $171.55, the shares rose to $175.795 and dropped to $171.18, the range by which the price of stock traded the whole day. The daily chart for CME points out that the company has recorded -12.95% loss over the past six months. However, it is still -32.51% lower than its most recent low trading price.

If we look at the average trading volume of 2.37M shares, CME reached to a volume of 1967094 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Here is what top equities market gurus are saying about CME Group Inc. [CME]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CME shares is $196.29 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CME stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Keefe Bruyette have made an estimate for CME Group Inc. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on April 14, 2020. The new note on the price target was released on March 30, 2020, representing the official price target for CME Group Inc. stock. Previously, the target price had yet another raise from $214 to $233, while UBS kept a Buy rating on CME stock.

The Average True Range (ATR) for CME Group Inc. is set at 6.18, with the Price to Sales ratio for CME stock in the period of the last 12 months amounting to 11.98. The Price to Book ratio for the last quarter was 2.35, with the Price to Cash per share for the same quarter was set at 2.60. Price to Free Cash Flow for CME in the course of the last twelve months was 120.07 with Quick ratio for the last quarter at 1.00.

Trading performance analysis for CME stock

CME Group Inc. [CME] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.92. With this latest performance, CME shares dropped by -3.25% in over the last four-week period, additionally sinking by -12.95% over the last 6 months – not to mention a drop of -10.29% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CME stock in for the last two-week period is set at 41.23, with the RSI for the last a single of trading hit 37.19, and the three-weeks RSI is set at 45.11 for CME Group Inc. [CME]. The present Moving Average for the last 50 days of trading for this stock 181.59, while it was recorded at 180.67 for the last single week of trading, and 197.88 for the last 200 days.

CME Group Inc. [CME]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and CME Group Inc. [CME] shares currently have an operating margin of +49.61 and a Gross Margin at +79.08. CME Group Inc.’s Net Margin is presently recorded at +43.37.

Return on Total Capital for CME is now 7.95, given the latest momentum, and Return on Invested Capital for the company is 7.03. Return on Equity for this stock inclined to 8.13, with Return on Assets sitting at 2.77. When it comes to the capital structure of this company, CME Group Inc. [CME] has a Total Debt to Total Equity ratio set at 16.84. Additionally, CME Total Debt to Total Capital is recorded at 14.41, with Total Debt to Total Assets ending up at 5.84. Long-Term Debt to Equity for the company is recorded at 16.65, with the Long-Term Debt to Total Capital now at 14.25.

Reflecting on the efficiency of the workforce at the company, CME Group Inc. [CME] managed to generate an average of $485,436 per employee. Receivables Turnover for the company is 9.34 with a Total Asset Turnover recorded at a value of 0.06.CME Group Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.00.

CME Group Inc. [CME]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, CME Group Inc. posted 1.76/share EPS, while the average EPS was predicted by analysts to be reported at 1.76/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CME. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CME Group Inc. go to 5.01%.

An analysis of insider ownership at CME Group Inc. [CME]

There are presently around $54,175 million, or 88.60% of CME stock, in the hands of institutional investors. The top three institutional holders of CME stocks are: CAPITAL WORLD INVESTORS with ownership of 34,927,278, which is approximately -2.425% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 29,369,141 shares of the stock with an approximate value of $5.13 billion in CME stocks shares; and BLACKROCK INC., currently with $4.66 billion in CME stock with ownership of nearly 4.634% of the company’s market capitalization.

Positions in CME Group Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 465 institutional holders increased their position in CME Group Inc. [NASDAQ:CME] by around 21,525,739 shares. Additionally, 514 investors decreased positions by around 19,311,283 shares, while 155 investors held positions by with 269,232,548 shares. The mentioned changes placed institutional holdings at 310,069,570 shares, according to the latest SEC report filing. CME stock had 85 new institutional investments in for a total of 3,709,085 shares, while 95 institutional investors sold positions of 1,021,026 shares during the same period.



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam